Literature DB >> 31377975

Attenuated MuV-S79 as vector stably expressing foreign gene.

Duo Zhou1, Meng-Ying Zhu1, Yi-Long Wang2, Xiao-Qiang Hao1, Dong-Ming Zhou3, Rong-Xian Liu1, Chu-Di Zhang1, Chu-Fan Qu1, Zheng-Yan Zhao4,5.   

Abstract

BACKGROUND: To describe mumps virus (MuV) used as a vector to express enhanced green fluorescent protein (EGFP) or red fluorescent protein (RFP) genes.
METHODS: Molecular cloning technique was applied to establish the cDNA clones of recombinant mumps viruses (rMuVs). rMuVs were recovered based on our reverse genetic system of MuV-S79. The properties of rMuVs were determined by growth curve, plaque assay, fluorescent microscopy and determination of fluorescent intensity.
RESULTS: Three recombinant viruses replicated well in Vero cells and similarly as parental rMuV-S79, expressed heterologous genes in high levels, and were genetically stable in at least 15 passages.
CONCLUSION: rMuV-S79 is a promising platform to accommodate foreign genes like marker genes, other antigens and immunomodulators for addressing various diseases.

Entities:  

Keywords:  Foreign genes; Mumps virus; Reverse genetic system

Mesh:

Substances:

Year:  2019        PMID: 31377975     DOI: 10.1007/s12519-019-00287-7

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  19 in total

1.  Immunogenicity of novel mumps vaccine candidates generated by genetic modification.

Authors:  Pei Xu; Zhenhai Chen; Shannon Phan; Adrian Pickar; Biao He
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

2.  The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection.

Authors:  Hui-Mei Hu; Hsin-Wei Chen; Yu-Ju Hsiao; Szu-Hsien Wu; Han-Hsuan Chung; Chun-Hsiang Hsieh; Pele Chong; Chih-Hsiang Leng; Chien-Hsiung Pan
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

3.  A recombinant measles virus expressing biologically active human interleukin-12.

Authors:  M Singh; M A Billeter
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

4.  Measles vector as a multigene delivery platform facilitating iPSC reprogramming.

Authors:  Qi Wang; Alanna Vossen; Yasuhiro Ikeda; Patricia Devaux
Journal:  Gene Ther       Date:  2019-02-04       Impact factor: 5.250

5.  The V protein of mumps virus plays a critical role in pathogenesis.

Authors:  Pei Xu; Priya Luthra; Zhuo Li; Sandra Fuentes; James Alexander D'Andrea; Jianguo Wu; Steven Rubin; Paul A Rota; Biao He
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

6.  A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.

Authors:  Chantal Combredet; Valérie Labrousse; Lucile Mollet; Clarisse Lorin; Frédéric Delebecque; Bruno Hurtrel; Harold McClure; Mark B Feinberg; Michel Brahic; Frédéric Tangy
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Trisaccharide containing α2,3-linked sialic acid is a receptor for mumps virus.

Authors:  Marie Kubota; Kaoru Takeuchi; Shumpei Watanabe; Shinji Ohno; Rei Matsuoka; Daisuke Kohda; Shin-Ichi Nakakita; Hiroaki Hiramatsu; Yasuo Suzuki; Tetsuo Nakayama; Tohru Terada; Kentaro Shimizu; Nobutaka Shimizu; Mitsunori Shiroishi; Yusuke Yanagi; Takao Hashiguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

8.  Recombinant mumps virus as a cancer therapeutic agent.

Authors:  Arun Ammayappan; Stephen J Russell; Mark J Federspiel
Journal:  Mol Ther Oncolytics       Date:  2016-08-10       Impact factor: 7.200

9.  Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein.

Authors:  Nicolas Escriou; Benoît Callendret; Valérie Lorin; Chantal Combredet; Philippe Marianneau; Michèle Février; Frédéric Tangy
Journal:  Virology       Date:  2014-01-28       Impact factor: 3.616

10.  Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine.

Authors:  Gaurav Gupta; Viviana Giannino; Narayan Rishi; Reinhard Glueck
Journal:  Vaccine       Date:  2016-08-11       Impact factor: 3.641

View more
  1 in total

1.  Population Variability Generated during Rescue Process and Passaging of Recombinant Mumps Viruses.

Authors:  Anamarija Slović; Tanja Košutić-Gulija; Dubravko Forčić; Maja Šantak; Maja Jagušić; Mirna Jurković; Dorotea Pali; Jelena Ivančić-Jelečki
Journal:  Viruses       Date:  2021-12-20       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.